(GE) GE Aerospace - Overview
Sector: IndustrialsIndustry: Aerospace & Defense | Exchange NYSE (USA) | Currency USD | Market Cap: 312.816m | Total Return 38.1% in 12m
Stock: Engines, Systems, Components, Power
Total Rating 76
Risk 87
Buy Signal -0.60
| Risk 5d forecast | |
|---|---|
| Volatility | 34.8% |
| Relative Tail Risk | -5.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.04 |
| Alpha | 24.21 |
| Character TTM | |
|---|---|
| Beta | 1.010 |
| Beta Downside | 0.783 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.36% |
| CAGR/Max DD | 2.63 |
EPS (Earnings per Share)
Revenue
Description: GE GE Aerospace March 04, 2026
GE Aerospace designs and produces aircraft engines, components, and systems for commercial and defense applications. The company operates in two segments: Commercial Engines & Services and Defense & Propulsion Technologies. The commercial segment focuses on jet engines, MRO, and spare parts for commercial aviation. The defense segment provides similar products and services to governments and militaries, along with aircraft components and systems under various brands.
The aerospace and defense sector is characterized by long product lifecycles and significant R&D investment. A substantial portion of revenue in this industry often comes from aftermarket services, such as MRO and spare parts sales.
Investors can find detailed financial analysis and performance metrics for GE Aerospace on ValueRay.
Headlines to watch out for
- Commercial airline traffic growth boosts engine and services demand
- Defense spending increases drive military engine orders
- Supply chain disruptions elevate production costs and delivery times
- Regulatory approvals impact new engine program timelines
- Fuel price volatility affects airline profitability and new aircraft orders
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 8.70b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.66 > 1.0 |
| NWC/Revenue: 3.52% < 20% (prev 8.38%; Δ -4.86% < -1%) |
| CFO/TA 0.07 > 3% & CFO 8.54b > Net Income 8.70b |
| Net Debt (8.10b) to EBITDA (12.06b): 0.67 < 3 |
| Current Ratio: 1.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.07b) vs 12m ago -1.67% < -2% |
| Gross Margin: 36.88% > 18% (prev 0.37%; Δ 3.65k% > 0.5%) |
| Asset Turnover: 35.86% > 50% (prev 30.77%; Δ 5.09% > 0%) |
| Interest Coverage Ratio: 12.86 > 6 (EBITDA TTM 12.06b / Interest Expense TTM 843.0m) |
Altman Z'' 3.63
| A: 0.01 (Total Current Assets 40.60b - Total Current Liabilities 38.98b) / Total Assets 130.17b |
| B: 0.67 (Retained Earnings 87.66b / Total Assets 130.17b) |
| C: 0.08 (EBIT TTM 10.84b / Avg Total Assets 127.97b) |
| D: 0.74 (Book Value of Equity 82.88b / Total Liabilities 111.27b) |
| Altman-Z'' Score: 3.63 = AA |
Beneish M -2.86
| DSRI: 1.05 (Receivables 15.28b/12.31b, Revenue 45.89b/38.70b) |
| GMI: 1.01 (GM 36.88% / 37.19%) |
| AQI: 0.97 (AQ_t 0.63 / AQ_t-1 0.64) |
| SGI: 1.19 (Revenue 45.89b / 38.70b) |
| TATA: 0.00 (NI 8.70b - CFO 8.54b) / TA 130.17b) |
| Beneish M-Score: -2.86 (Cap -4..+1) = A |
What is the price of GE shares?
As of March 28, 2026, the stock is trading at USD 282.81 with a total of 3,270,450 shares traded.
Over the past week, the price has changed by -1.39%, over one month by -17.25%, over three months by -9.10% and over the past year by +38.09%.
Over the past week, the price has changed by -1.39%, over one month by -17.25%, over three months by -9.10% and over the past year by +38.09%.
Is GE a buy, sell or hold?
GE Aerospace has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy GE.
- StrongBuy: 13
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 362.8 | 28.3% |
| Analysts Target Price | 362.8 | 28.3% |
GE Fundamental Data Overview March 27, 2026
P/E Trailing = 36.8856
P/E Forward = 38.4615
P/S = 6.8218
P/B = 16.0436
P/EG = 4.9386
Revenue TTM = 45.89b USD
EBIT TTM = 10.84b USD
EBITDA TTM = 12.06b USD
Long Term Debt = 18.81b USD (from longTermDebt, last quarter)
Short Term Debt = 1.69b USD (from shortTermDebt, last quarter)
Debt = 20.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.10b USD (from netDebt column, last quarter)
Enterprise Value = 320.92b USD (312.82b + Debt 20.49b - CCE 12.39b)
Interest Coverage Ratio = 12.86 (Ebit TTM 10.84b / Interest Expense TTM 843.0m)
EV/FCF = 44.18x (Enterprise Value 320.92b / FCF TTM 7.26b)
FCF Yield = 2.26% (FCF TTM 7.26b / Enterprise Value 320.92b)
FCF Margin = 15.83% (FCF TTM 7.26b / Revenue TTM 45.89b)
Net Margin = 18.96% (Net Income TTM 8.70b / Revenue TTM 45.89b)
Gross Margin = 36.88% ((Revenue TTM 45.89b - Cost of Revenue TTM 28.97b) / Revenue TTM)
Gross Margin QoQ = 34.24% (prev 36.49%)
Tobins Q-Ratio = 2.47 (Enterprise Value 320.92b / Total Assets 130.17b)
Interest Expense / Debt = 1.22% (Interest Expense 250.0m / Debt 20.49b)
Taxrate = 13.68% (390.0m / 2.85b)
NOPAT = 9.36b (EBIT 10.84b * (1 - 13.68%))
Current Ratio = 1.04 (Total Current Assets 40.60b / Total Current Liabilities 38.98b)
Debt / Equity = 1.10 (Debt 20.49b / totalStockholderEquity, last quarter 18.68b)
Debt / EBITDA = 0.67 (Net Debt 8.10b / EBITDA 12.06b)
Debt / FCF = 1.12 (Net Debt 8.10b / FCF TTM 7.26b)
Total Stockholder Equity = 18.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.80% (Net Income 8.70b / Total Assets 130.17b)
RoE = 45.88% (Net Income TTM 8.70b / Total Stockholder Equity 18.97b)
RoCE = 28.70% (EBIT 10.84b / Capital Employed (Equity 18.97b + L.T.Debt 18.81b))
RoIC = 24.05% (NOPAT 9.36b / Invested Capital 38.92b)
WACC = 9.02% (E(312.82b)/V(333.31b) * Re(9.54%) + D(20.49b)/V(333.31b) * Rd(1.22%) * (1-Tc(0.14)))
Discount Rate = 9.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.51%
[DCF] Terminal Value 76.16% ; FCFF base≈5.83b ; Y1≈6.35b ; Y5≈8.01b
[DCF] Fair Price = 104.1 (EV 116.84b - Net Debt 8.10b = Equity 108.74b / Shares 1.04b; r=9.02% [WACC]; 5y FCF grow 10.22% → 3.0% )
EPS Correlation: 75.96 | EPS CAGR: 65.01% | SUE: 3.14 | # QB: 5
Revenue Correlation: -36.36 | Revenue CAGR: 0.09% | SUE: 0.38 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.81 | Chg7d=+0.000 | Chg30d=-0.005 | Revisions Net=-3 | Analysts=15
EPS current Year (2026-12-31): EPS=7.43 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=+3 | Growth EPS=+16.7% | Growth Revenue=+14.0%
EPS next Year (2027-12-31): EPS=8.55 | Chg7d=+0.000 | Chg30d=+0.052 | Revisions Net=+3 | Growth EPS=+15.1% | Growth Revenue=+10.3%
[Analyst] Revisions Ratio: -0.27 (4 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 9.5% - Earnings Yield 2.7%)
[Growth] Growth Spread = +8.1% (Analyst 14.9% - Implied 6.8%)
P/E Forward = 38.4615
P/S = 6.8218
P/B = 16.0436
P/EG = 4.9386
Revenue TTM = 45.89b USD
EBIT TTM = 10.84b USD
EBITDA TTM = 12.06b USD
Long Term Debt = 18.81b USD (from longTermDebt, last quarter)
Short Term Debt = 1.69b USD (from shortTermDebt, last quarter)
Debt = 20.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.10b USD (from netDebt column, last quarter)
Enterprise Value = 320.92b USD (312.82b + Debt 20.49b - CCE 12.39b)
Interest Coverage Ratio = 12.86 (Ebit TTM 10.84b / Interest Expense TTM 843.0m)
EV/FCF = 44.18x (Enterprise Value 320.92b / FCF TTM 7.26b)
FCF Yield = 2.26% (FCF TTM 7.26b / Enterprise Value 320.92b)
FCF Margin = 15.83% (FCF TTM 7.26b / Revenue TTM 45.89b)
Net Margin = 18.96% (Net Income TTM 8.70b / Revenue TTM 45.89b)
Gross Margin = 36.88% ((Revenue TTM 45.89b - Cost of Revenue TTM 28.97b) / Revenue TTM)
Gross Margin QoQ = 34.24% (prev 36.49%)
Tobins Q-Ratio = 2.47 (Enterprise Value 320.92b / Total Assets 130.17b)
Interest Expense / Debt = 1.22% (Interest Expense 250.0m / Debt 20.49b)
Taxrate = 13.68% (390.0m / 2.85b)
NOPAT = 9.36b (EBIT 10.84b * (1 - 13.68%))
Current Ratio = 1.04 (Total Current Assets 40.60b / Total Current Liabilities 38.98b)
Debt / Equity = 1.10 (Debt 20.49b / totalStockholderEquity, last quarter 18.68b)
Debt / EBITDA = 0.67 (Net Debt 8.10b / EBITDA 12.06b)
Debt / FCF = 1.12 (Net Debt 8.10b / FCF TTM 7.26b)
Total Stockholder Equity = 18.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.80% (Net Income 8.70b / Total Assets 130.17b)
RoE = 45.88% (Net Income TTM 8.70b / Total Stockholder Equity 18.97b)
RoCE = 28.70% (EBIT 10.84b / Capital Employed (Equity 18.97b + L.T.Debt 18.81b))
RoIC = 24.05% (NOPAT 9.36b / Invested Capital 38.92b)
WACC = 9.02% (E(312.82b)/V(333.31b) * Re(9.54%) + D(20.49b)/V(333.31b) * Rd(1.22%) * (1-Tc(0.14)))
Discount Rate = 9.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.51%
[DCF] Terminal Value 76.16% ; FCFF base≈5.83b ; Y1≈6.35b ; Y5≈8.01b
[DCF] Fair Price = 104.1 (EV 116.84b - Net Debt 8.10b = Equity 108.74b / Shares 1.04b; r=9.02% [WACC]; 5y FCF grow 10.22% → 3.0% )
EPS Correlation: 75.96 | EPS CAGR: 65.01% | SUE: 3.14 | # QB: 5
Revenue Correlation: -36.36 | Revenue CAGR: 0.09% | SUE: 0.38 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.81 | Chg7d=+0.000 | Chg30d=-0.005 | Revisions Net=-3 | Analysts=15
EPS current Year (2026-12-31): EPS=7.43 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=+3 | Growth EPS=+16.7% | Growth Revenue=+14.0%
EPS next Year (2027-12-31): EPS=8.55 | Chg7d=+0.000 | Chg30d=+0.052 | Revisions Net=+3 | Growth EPS=+15.1% | Growth Revenue=+10.3%
[Analyst] Revisions Ratio: -0.27 (4 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 9.5% - Earnings Yield 2.7%)
[Growth] Growth Spread = +8.1% (Analyst 14.9% - Implied 6.8%)